Compare Enzyme (MLN) vs Saros (SAROS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Saros — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Saros trades at Rp8.79 (market cap Rp29,34M, Rp14,91M 24h volume). The key difference: Enzyme is far larger — about 4.6× Saros's market cap, and Saros's supply is capped (3,5B / 10B SAROS (36%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Saros for 21 Days on average.
| MLN | SAROS | |
|---|---|---|
Market Cap | Rp134,13M | Rp29,34M |
Volume (24h) | Rp104,56M | Rp14,91M |
Circulating Supply | 3,3M MLN | 3,5B / 10B SAROS (36%) |
Typical Hold Time | 28 Days | 21 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Saros (SAROS) is currently trading at Rp7.49 with a market cap of Rp25.22M, showing a bearish technical signal as indicated by moving averages. The asset has a circulating supply of 3.5M tokens out of a maximum 10M, with a circulation rate of 36%. Key technical indicators show neutral oscillators and mixed signals from RSI and ADX. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious due to bearish technicals and low market cap, presenting high volatility risks. Key opportunities include potential growth from increased adoption, but major risks involve low liquidity and regulatory uncertainties. Investors should monitor trading volume and on-chain activity closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Saros
Saros is a digital identity platform and super app on the Solana blockchain. It started with the SarosSwap decentralized exchange and has grown into a full Web3 ecosystem. Its non-custodial wallet features Social Login, Watch-only mode, and an NFC hybrid wallet for better security and convenience. The wallet integrates with SolanaPay, facilitating efficient transactions through an in-house payment module.
Read more on SAROS →
